Thomas Garner
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Jennifer J. Rhodes, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Thomas Garner:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Restricted Stock Units | 28,493 | $762,703 | $16.81 | 06 Mar 2026 | Direct |
| LEXICON PHARMACEUTICALS, INC. | SVP, Chief Commercial Officer | Restricted Stock Units | 227,130 | $239,236 | $1.05 | 08 Feb 2024 | Direct |
| LEXICON PHARMACEUTICALS, INC. | SVP, Chief Commercial Officer | Stock Option (Right to Buy) | 227,130 | 08 Feb 2024 | Direct | ||
| ACADIA PHARMACEUTICALS INC | EVP, Chief Commercial Officer | Stock Option (Right to Buy) | 97,947 | 06 Mar 2026 | Direct |
Insider Reports Filed by Thomas Garner
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 06 Mar 2026 | 2 | $0 | 4 | EVP, Chief Commercial Officer | 10 Mar 2026, 18:00 |
| ACAD | ACADIA PHARMACEUTICALS INC | 09 Dec 2024 | 2 | $0 | 4 | EVP, Chief Commercial Officer | 10 Dec 2024, 18:33 |
| ACAD | ACADIA PHARMACEUTICALS INC | 09 Dec 2024 | 0 | $0 | 3 | EVP, Chief Commercial Officer | 10 Dec 2024, 18:31 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 08 Feb 2024 | 2 | $0 | 4 | SVP, Chief Commercial Officer | 12 Feb 2024, 16:14 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 09 Oct 2023 | 1 | $0 | 4 | SVP, Chief Commercial Officer | 11 Oct 2023, 16:02 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 09 Oct 2023 | 0 | $0 | 3 | SVP, Chief Commercial Officer | 11 Oct 2023, 16:01 |